Tamaki K - Search Results

1

Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts.

Ihn H, Yamane K, Tamaki K. Ihn H, et al. Among authors: tamaki k. J Invest Dermatol. 2005 Aug;125(2):247-55. doi: 10.1111/j.0022-202X.2005.23766.x. J Invest Dermatol. 2005. PMID: 16098034 Free article.

2

IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway.

Ihn H, Yamane K, Asano Y, Kubo M, Tamaki K. Ihn H, et al. Among authors: tamaki k. J Immunol. 2002 Feb 15;168(4):1895-902. doi: 10.4049/jimmunol.168.4.1895. J Immunol. 2002. PMID: 11823524

3

Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.

Yamane K, Ihn H, Kubo M, Tamaki K. Yamane K, et al. Among authors: tamaki k. Arthritis Rheum. 2002 Sep;46(9):2421-8. doi: 10.1002/art.10477. Arthritis Rheum. 2002. PMID: 12355490 Free article.

4

Mitogenic activity of dermatofibrosarcoma protuberans is mediated via an extracellular signal related kinase dependent pathway.

Ihn H, Tamaki K. Ihn H, et al. Among authors: tamaki k. J Invest Dermatol. 2002 Oct;119(4):954-60. doi: 10.1046/j.1523-1747.2002.00383.x. J Invest Dermatol. 2002. PMID: 12406344 Free article.

5

Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.

Kubo M, Ihn H, Yamane K, Tamaki K. Kubo M, et al. Among authors: tamaki k. J Rheumatol. 2002 Dec;29(12):2558-64. J Rheumatol. 2002. PMID: 12465152

6

The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.

Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Asano Y, et al. Among authors: tamaki k. J Invest Dermatol. 2003 Feb;120(2):204-10. doi: 10.1046/j.1523-1747.2003.12028.x. J Invest Dermatol. 2003. PMID: 12542523 Free article.

7

Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.

Yamane K, Ihn H, Tamaki K. Yamane K, et al. Among authors: tamaki k. Arthritis Rheum. 2003 Jun;48(6):1652-66. doi: 10.1002/art.11029. Arthritis Rheum. 2003. PMID: 12794834 Free article.

8

Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.

Yamane K, Ihn H, Asano Y, Jinnin M, Tamaki K. Yamane K, et al. Among authors: tamaki k. J Immunol. 2003 Oct 1;171(7):3855-62. doi: 10.4049/jimmunol.171.7.3855. J Immunol. 2003. PMID: 14500687

9

Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.

Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Asano Y, et al. Among authors: tamaki k. J Clin Invest. 2004 Jan;113(2):253-64. doi: 10.1172/JCI16269. J Clin Invest. 2004. PMID: 14722617 Free PMC article.

10

Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.

Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Jinnin M, et al. Among authors: tamaki k. Oncogene. 2004 Mar 4;23(9):1656-67. doi: 10.1038/sj.onc.1207064. Oncogene. 2004. PMID: 15001984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,196 results

Search Page

Filters